Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Filings indexed 662 across all filing types
Latest filing 2022-04-25 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
股东大会议事规则(2022年4月)
Governance Information Classification · 100% confidence The document is titled "华蓝集团股份公司 股东大会议事规则" which translates to "Rules of Procedure for the Shareholders' General Meeting of Hualan Group Co., Ltd." It is a detailed procedural document outlining the governance, powers, convening, proposals, voting, and resolutions of the shareholders' meetings. It references laws, regulations, and company bylaws related to shareholder meetings. The content is about the internal rules and procedures governing the conduct of shareholder meetings rather than an announcement, report, or minutes of a specific meeting. It does not contain financial data, voting results, or management changes. Therefore, it fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-04-25 Chinese
对外投资管理制度(2022年4月)
Governance Information Classification · 95% confidence The document is titled '对外投资管理制度' (External Investment Management System) and dated April 2022. It outlines the company's internal policies and procedures for managing external investments, including approval authorities, organizational responsibilities, financial management, and auditing. It references relevant laws and stock exchange listing rules but does not contain financial statements, earnings data, or audit opinions. It is a governance or internal control document related to investment management rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-04-25 Chinese
2021年度监事会工作报告
Board/Management Information Classification · 90% confidence The document is titled as the "2021 年监事会工作报告" which translates to "2021 Supervisory Board Work Report". It details the supervisory board's activities, oversight of financial reports, internal controls, compliance with laws and regulations, and audit opinions for the year 2021. It includes references to the audit report by an accounting firm but does not itself contain full financial statements or detailed financial data. The document is a report on the supervisory board's work and oversight rather than a full annual report or audit report. It is not a short announcement or certification but a substantive report on governance and supervisory activities. This fits best under the category of Board/Management Information (MANG), as it relates to the supervisory board's oversight and governance activities rather than the full annual report or audit report itself.
2022-04-25 Chinese
2021年独立董事述职报告-陈永利
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2021 Annual Work Report" for a company. It details the independent director's attendance at board meetings and shareholder meetings, opinions on company matters, investigations, protection of investor rights, committee work, training, and other related activities during the 2021 fiscal year. The content is a narrative report of the independent director's duties and activities rather than a financial report or regulatory filing. It is not an announcement of voting results, not a proxy solicitation, nor a remuneration report. It is a specific report by an independent director on their annual work, which fits best under Board/Management Information (MANG) as it relates to management and board-level disclosures about governance and director activities. The document length is 2859 characters, which is relatively short but contains substantive content about the director's work rather than just an announcement or certification. Therefore, the best classification is MANG with high confidence.
2022-04-25 Chinese
关于2021年计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 华蓝集团股份公司 regarding the impairment provision for the year 2021. It details the impairment testing, accounting policies, and the impact on the company's financials. The document is relatively short (2877 characters) and focuses on the impairment provision announcement rather than presenting a full financial report. It includes specific impairment amounts and accounting methods but does not contain comprehensive financial statements or a full annual or interim report. It also mentions that the impairment provision has been audited and confirmed by an accounting firm. Given the nature of the content and length, this document is best classified as a Regulatory Filing (RNS) because it is an announcement of impairment provisions and related accounting information, not a full Annual Report (10-K) or Interim Report (IR).
2022-04-25 Chinese
2022年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022 年第一季度报告' which translates to '2022 First Quarter Report'. It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes on non-recurring items. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the first quarter of 2022. It also mentions that the report is unaudited. The length of the document (over 13,000 characters) and the presence of detailed financial data confirm it is a full interim financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2022-04-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.